chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Developed fatigue, arm soreness, and headache within a few hours of the shot. By nightfall, the headache had grown much worse. The following morning when I woke (about 16 hours after the shot), I was nauseated and my whole body ached, especially my joints. My headache was severe, and the fatigue was much worse too. I developed a fever soon after waking that worsened to over 101 degrees by midday. My normal temperature is 97.2-97.6 so 101 is quite high for me. In short, I was miserable. I had covid for a month last February, but the side effects from the shot were worse, at least for me. This was like condensing the symptoms I had during the month I was sick with covid into a 24-hour period. Excruciating. By this morning (40 hours after shot), the worst of the side effects are over. I still have a mild, lingering headache, tiredness, and body aches, but I'm 90% better than I was this time yesterday.
Initial report received from a healthcare professional on 23 JULY 2013. A 41-year-old female patient, who had no significant medical history or illness at the time of vaccination had received a subcutaneous dose of MENACTRA (batch number: U4428AA) in the left arm, an intramuscular first dose of ADACEL (batch number U4667AA) in the left deltoid and an intradermal dose of TUBERSOL (batch number C4283AA) in the left forearm all on 12 JULY 2013. The patient's concomitant drugs were not reported. It was reported that the patient received a subcutaneous dose of MENACTRA instead of an intramuscular dose thus the patient received the vaccine by wrong route. On 14 JULY 2013, 2 days after vaccination, the patient developed 25 mm red, itchy and painful area at injection site and the left arm was sore. Laboratory investigations and corrective treatments were not reported. At the time of this report, the patient was 97% back to normal however had not recovered completely. Follow up information received from a healthcare professional on 12 SEPTEMBER 2013. It was reported that the patient had received several previous doses of TUBERSOL 5 TU on unspecified dates in past. The patient had received dose 1 of MENACTRA on 12 JULY 2013. No laboratory tests done. On contacting the patient on 25 JULY 2013, it was reported that there was no soreness or redness at the injection site. It was determined that any adverse reaction had resolved and no further evaluation was necessary. The patient had recovered from all the events on an unspecified date. Documents held by sender: none
Patient presented to ED  on 4/22/2021 with non-productive cough, mild shortness of breath x 10 days. Acute onset chest pain x 1 day. Chronic bilateral leg swelling, but worsening leg pain. Hx of DVT and PE, not on anti-coagulation.
Injection site/arm feels hot to touch, not swollen, red. Pt feels weak. Went to urgent care Rx MEDROL dose pack low-dose steroid inj. in hip.
I had headache, body ache and low grade fever forv2 days.  I had vomiting within 24 hours.  I still have diarrhea when eating 6 days later.
Local effects of vaccines. Recommendations given include: warm compress and clean area well TID. Pt's mother was advised to call if there is no improvement and to call if new or worsening symptoms.
2/6 - 2/7/22 pt in Hospital with sx of cough, congestion, poor oral intake, SOB, weakness, AMS, nausea, body aches; positive COVID test, acute renal failure; DNR/DNI; family decided to transition pt to hospice; dc'd to home where pt passed away
Information has been received from a registered nurse referring to an unspecified number of patients of unknown age and gender. On unspecified dates, doses of (Merck) VARIVAX (lot number L004653, expiration date 11-FEB-2017; route unspecified), which were exposed to temperatures outside of the recommended range, had been administered to the unspecified patients. No adverse experience had been reported. Additional information has been requested.
The afternoon of the vax, the pt developed swelling and burning of her cheeks, bumps on her right cheek and painful lips. She described the burning "like sunburn".
Patient received second dose of Moderna at 11:45 PM and went to waiting area for 30 min wait.  She has a h/o anaphaxisis type reaction to IVP dye.  No problems reported with first dose of vaccination.  At 12:03 PM, writer was summoned to waiting area as patient was c/o chest pressure.  Patient had frequent coughing.  Denied SOB.  States that she forgot her albuterol inhaler at home.  Denies throat closure.  Reports feeling sweaty and c/o chest pressure.  Lungs with upper airway wheezing.  Frequent dry-sounding cough.    VSS.  First responder called to assist with prompt arrival.  Initially, patient reported that symptoms were improving.  Still with frequent cough.  Then c/o throat tightness.    Was taken to ED via wheelchair accompanied by her husband.
Tingling starting at shoulder, going across the collar bone and up to the face, covering about half of face including tongue. This reaction began after first dose administration. This began about 20 minutes after first dose, never fully went away and happened again with second dose administration. No swelling, shortness of breathe or other symptoms, just "tingling" feeling
Administered vaccine after 33 days in the refrigerator; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administered vaccine after 33 days in the refrigerator) in a 68-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 005C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 18-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 18-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administered vaccine after 33 days in the refrigerator). On 18-Oct-2021, EXPIRED PRODUCT ADMINISTERED (Administered vaccine after 33 days in the refrigerator) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication provided by reporter. No treatment medication provided by reporter.
peripheral neuropathy-no treatment yet- 11 or 12 days after 1st Moderna  shot my fingers and feet are burning, tingling, muscle spams in legs.
No additional adverse effect reported; patient received a second dose of GARDASIL9 earlier than the dosing regimen indicated in PI; This spontaneous report was received from a licensed practical nurse and refers to a patient of unknown age and gender. No information regarding the patient's medical history, concurrent conditions, drug reactions or allergies and concomitant medications was provided.  On 01-JUL-2020, the patient was vaccinated with a first dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) injection, intramuscularly (dose, anatomical location, lot # and expiration date were not reported) for prophylaxis. On 30-JUL-2020 (reported as earlier than the dosing regimen indicated in package insert (PI)), the patient was vaccinated with a second dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) injection, intramuscularly, lot # S028737 and expiration date 03-APR-2022 (dose and anatomical location were not reported) for prophylaxis. No additional adverse effect was reported. combinationproductreport: Yes; brandname: GARDASIL 9 SYRINGE (DEVICE); commondevicename: HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast); productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp.; devicelotnumber: S028737; expirationdate: 03-APR-2022; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Unknown; evaluatedbymfr: Not returned to manufacturer; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not meet the criteria for Reportability
woke up w/welts under rt breast & spread to back;no fever, some swelling & heat from welts;
Information has been received from a nurse referring to a 4 year old unknown gender patient. Information about concomitant medications, pertinent medical history and drug reactions/allergies was not reported. On 19-FEB-2019, the patient was vaccinated with 1 dose of M-M-R II(lot # R024903, Expiration date: 30-AUG-2020 dose, frequency, route were not reported) and 1 dose of PROQUAD(lot #: R023499, expiration date: 13-FEB-2020, dose, frequency and route were not reported) for prophylaxis(incorrect dose administered). No adverse effects. Information about treatment given for the event, lab diagnostics/studies and medical attention was not provided.
Patient developed rashes around her chests and back after 2-3 days she received high dose flu shot (FLUZONE). Pt claimed it is very itchy and is not getting any better after she took BENADRYL and cortisone cream.
health has totally deteriorated; She sleeps, barely opens her eye; refuses to eat or drink; dizzy; didn't feel well; she can't talk, walk or anything; she can't talk, walk or anything; She is weak and frail; This is a spontaneous report from a contactable consumer (patient's daughter). A 100-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiry date not reported), via an unspecified route of administration on 10Jan2021 at single dose for COVID-19 immunization. Medical history included dementia from an unknown date and unknown if ongoing and walking aid user from an unknown date and unknown (prior to the vaccine, she walked well with her walker). Concomitant medication included quetiapine. The reporter reported that the patient's health has totally deteriorated as of a few days after receiving the vaccine on 13Jan2021. She is dying. She sleeps, barely opens her eyes and refuses to eat or drink. Three days after receiving the vaccine on 13Jan2021, she said she was dizzy and didn't feel well. Now she can't talk, walk or anything. She is weak and frail. Prior to the vaccine, she walked well with her walker, ate well and had energy. The reporter visited with her and had conversations but the patient doesn't talk or respond. She is her daughter and POA. She lives in the facility due to dementia. No treatment was received for the events. The patient did not recover from the events.  Information on the lot/batch number has been requested.
itching (constantly) and swollen lymphoid on my neck and collarbone area (left side)
Severe tingling in left fingertips. Started briefly in right hand around 15:30, before fading in right hand and starting in left hand. Tingling continued for 2+ hours and started to fade around 18:00.
Dizziness, lack of ability to concentrate, eye pain, neck pain onset 2/19/22.  Sore throat on 2/27/22.  Tonsillitis on exam on 3/1/22 with antibiotic Cefdinir ordered on 3/1/22. (Grossly inflamed, red, swollen, painful, white-patched tonsils. Muffled voice. Low grade fevers. Congestion.) Worsening condition on 3/3/22 that prompted laboratory testing for mononucleosis. Confirmed mononucleosis on 3/4/22.
no adverse effect; administered improperly stored vaccines; This spontaneous report was received from a medical assistant  referred to a patient of an unknown age and gender. The patient's medical history and concomitant medications were not reported. On 24-MAY-2019, the patient was inadvertently administered doses of improperly stored measles, mumps, rubella and varicella (oka-merck) virus vaccine live(PROQUAD)(Dosing details, route, frequency and indication were unknown) with lot number S000623 and expiry date 06-JUL-2020 and lot# R030799 and expiry date 22-APR-2020)(product storage error). Concomitant therapies included sterile diluent. All lots of measles, mumps, rubella and varicella (oka-merck) virus vaccine live(PROQUAD) was reconstituted with properly stored diluent. No adverse effects were reported(No adverse event). There was no previous temperature excursion. The temperature was - 10 degree Celsius and time frame was 3 hours. No further information was provided.  This is one of the three reports received from the same reporter.
Information has been received from a consumer concerning her 12 year old daughter with asthma who was vaccinated with her first dose of Gardasil via injection. Concomitant therapy included influenza virus vaccine (unspecified). The mother reported that two to three hours after her daughter received the vaccine she developed signs of asthma which included wheezing. The patient was treated with a nebulizer. The wheezing continued for two to three days and then ceased. The mother mentioned that her daughter had a history of asthma, however, she had not had an asthmatic episode in a while. The patient also received a flu vaccine the same day (unspecified). Additional information has been requested. This is in follow-up to report(s) previously on 12/14/2007. Information has been received from a consumer concerning her 12 year old daughter with asthma who was vaccinated with her first dose of GARDASIL (Lot #658222/0827U) intramuscularly in the left arm. Concomitant therapy included influenza virus vaccine (Lot #U2452AA) intramuscularly in the right arm. The mother reported that two to three hours after her daughter received the vaccine she developed signs of asthma which included wheezing and coughing. The patient was treated with a nebulizer, an inhaler, and 2 courses of oral steroids. The wheezing continued for two to three days and then ceased. The patient is now better but she is still coughing. The mother mentioned that her daughter had a history of asthma.However, she had not had an asthmatic episode in over 2 years. The patient also received a flu vaccine the same day (unspecified).
12x12cm sl indurated, well defined raised erythematous area;very warm to touch;surrounds sl inj site;lt anterior thigh;given DPH;
body aches; Breast Pain; vomitting; headache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (body aches), BREAST PAIN (Breast Pain), VOMITING (vomitting) and HEADACHE (headache) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN (body aches), BREAST PAIN (Breast Pain), VOMITING (vomitting) and HEADACHE (headache). At the time of the report, PAIN (body aches), BREAST PAIN (Breast Pain), VOMITING (vomitting) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.  No treatment information was provided.
SWOLLEN LEG; UNABLE TO WALK; This spontaneous report received from a patient via company representative concerned a female of unspecified age, race and ethnicity. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown, Expiry: Unknown) 1 total, dose not reported, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, patient was hospitalized (date unspecified) for 9 days immediately after receiving the Janssen Covid-19 vaccine with swollen leg and was unable to walk. The patient reports that she will be receiving physical therapy to help her recover. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the swollen leg and unable to walk was not reported. This report was serious (Hospitalization Caused / Prolonged).; Sender's Comments: V0: 20210946668-covid-19 vaccine ad26.cov2.-swollen leg, unable to walk. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).
Patient was under 18 when she received vaccine, she is not having any adverse events to the injection.
Fine on day of injection. Following morning woke up with fever, achy.  Arm at injection site was red, hot, swollen.  Had fever (from 99.9 to 101.7) 3 days.  Finally feeling  better on Sunday.  Temperature is down to 98.6 (my normal temp is 96).  Achy feeling almost gone.  Arm is still  red, hot, swollen.
On 08/20/2021 progressively became worse, it got harder and harder for me to roll over at night, I could barely walk . The 1st time I went to he chiropractor 09/01/2021 to try to get some relief.  I cant get in and out of the car. I could barely get out of bed, I could barely walk. I have not been able to work since this happened. On 09/02/2021 and 09/03/2021 I went back to the chiropractor. They did an x-ray and said my sciatic nerve was irritated and they adjusted me and called it a lower lumbar decompression. I went back the chiropractor on  09/08/2021,  09/10/2021, & the  09/11/2021,  I told him I could not stand the pain and he told me I would have to see a doctor to get any type of pain relief. On 09/13/2021 I went to Family Care. They gave me a steroid shot and pain shot,  muscle relaxer- Metho Carbamol 750 mg and a steroid pack, Prednisone-I had to take for a week . As soon as those steroids wore off I had to go back again which was 09/19/2021. On 09/19/2021- they gave me another steroid shot and pain shot and 2 different types of medications: Mobic, & Tramadol.  It feels like a lightning bolt from my buttocks, down my Left leg, down my calf, to my foot. There is nothing I did that caused it, as far as me doing something physical. I can't even function. It's just painful.
This spontaneous report as received from a nurse refers to a 65 years old male patient with no drug reactions/allergies. The patient's medical history included cancer. The patient was vaccinated with a dose of ZOSTAVAX (Lot # reported as H013900) subcutaneously on 13-NOV-2012. No concomitant medications were reported. The nurse called stating the patient received ZOSTAVAX on 13-NOV-2012 developing Ramsey Hunt Syndrome and was hospitalized. The patient started to experience symptoms on 20-NOV-2012. The patient saw his primary care physician initially. He was also referred to an ENT (Ear, Nose and Throat) specialist on 07-DEC-2012. CT scan, lab work and spinal tab were performed without any results. However his symptoms exacerbated and he was hospitalized on 12-DEC-2012 and spent 3 to 4 days in the hospital. The patient was still experiencing deafness in one ear, trouble swallowing and partial paralysis of his throat. He was still recuperating at home. He was prescribed acyclovir for his condition. The patient had a history of cancer however he was in remission for the past year and had not received any therapy related to cancer in the past year. At the time of reporting, the outcome was reported as recovering. Additional information has been requested.
small cancer/cancer thing in her breast/The cancer was weeks ago; This spontaneous case was reported by a consumer and describes the occurrence of BREAST CANCER (small cancer/cancer thing in her breast/The cancer was weeks ago) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029L20A and 025A21A) for COVID-19 vaccination.     The patient's past medical history included Heart attack. Concurrent medical conditions included Asthma and Blood cholesterol abnormal. Concomitant products included OXYGEN for Heart attack.   On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced BREAST CANCER (small cancer/cancer thing in her breast/The cancer was weeks ago) (seriousness criterion medically significant). At the time of the report, BREAST CANCER (small cancer/cancer thing in her breast/The cancer was weeks ago) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Biopsy: abnormal (abnormal) Cancer.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant products included 9 prescription medications, blood thinners, blood pressure pills, cholesterol thing and inhaler in the morning for asthma. A few weeks prior to this report, the patient was found to have a small cancer and she mentioned that she had a cancer thing in her breast. The patient had a biopsy, and the results of the biopsy mentioned cancer, a small cancer. The patient mentioned that it was not worried since it has being caught early. Patient had an appointment with cardiologist and a surgery (lumpectomy) scheduled for 06-Nov-2021. No treatment medications were reported.  Company comment: This case concerns an 82-year-old female patient with medical history of heart attack, who experienced the unexpected and serious event of breast cancer. The event occurred on an unknown number of months after first and second doses of Moderna COVID-19 Vaccine were administered. The rechallenge is not applicable as the event occurred after the second dose. Patient´s age and gender remain as confounders. The benefit-risk relationship of Moderna COVID-19 Vaccine is not affected by this report.   This case was linked to MOD-2021-366719 (Patient Link).; Sender's Comments: This case concerns an 82-year-old female patient with medical history of heart attack, who experienced the unexpected and serious event of breast cancer. The event occurred on an unknown number of months after first and second doses of Moderna COVID-19 Vaccine were administered. The rechallenge is not applicable as the event occurred after the second dose. Patient´s age and gender remain as confounders. The benefit-risk relationship of Moderna COVID-19 Vaccine is not affected by this report.
Received chicken pox inj SC on Rt leg on 3-8-14. Developed a red raised lump. Measurement today 1" x 1/2" diameter.
rash; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of RASH (rash) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced RASH (rash). At the time of the report, RASH (rash) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   no concomitant and treatment medications were provided.